Skip to main content

Vira Shield 6+VL5 Somnus

This page contains information on Vira Shield 6+VL5 Somnus for veterinary use.
The information provided typically includes the following:
  • Vira Shield 6+VL5 Somnus Indications
  • Warnings and cautions for Vira Shield 6+VL5 Somnus
  • Direction and dosage information for Vira Shield 6+VL5 Somnus

Vira Shield 6+VL5 Somnus

This treatment applies to the following species:
Company: Elanco US (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Campylobacter Fetus-Haemophilus Somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

Vira Shield 6+VL5 Somnus Indications

This product has been shown to be effective for the vaccination of healthy cattle against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Haemophilus somnus, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity against BVD Type 2 is at least 11 months and Campylobacter fetus is at least 12 months. The duration for the remaining antigens in this product has not been determined. For more information regarding efficacy and safety data, see

Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.


Directions For Use

Shake well before using. Administer 5 mL intramuscularly in the neck 2 to 4 weeks prior to breeding. Revaccinate with Vira Shield 6 + Somnus (Code 44C5.20) in 4 to 5 weeks. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For advice on revaccination, contact a veterinarian.


Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN 196/44M5.20

Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

50 mL


50 Doses

250 mL


CPN: 1114097.5

Distributed by ELANCO US, INC.
Customer Service:   317-276-1262
Technical Service:   800-428-4441
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-02-28